Vertex Pharmaceuticals (VRTX) Long-Term Debt Repayments (2011 - 2018)
Vertex Pharmaceuticals' quarterly Long-Term Debt Repayments came in at $8.1 million in Q4 2018, up 76.56% year-on-year from $4.6 million in Q4 2017, and up 41.93% quarter-over-quarter from $5.7 million in Q3 2018.
Vertex Pharmaceuticals has reported Long-Term Debt Repayments for 8 years, with the latest figure at $8.1 million in Q4 2018.
- For the quarter ending Q4 2018, Long-Term Debt Repayments rose 76.56% year-over-year to $8.1 million; the trailing twelve-month figure through Dec 2018 stood at $27.9 million (up 48.58% YoY), and the FY2018 full-year result was $27.9 million, up 48.58% from the prior year.
- Long-Term Debt Repayments for Q4 2018 stood at $8.1 million, up from $5.7 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $264.1 million in Q3 2014, with the low at -$272.9 million in Q4 2014.
- Average Long-Term Debt Repayments over 5 years is $5.3 million, with a median of $4.8 million recorded in 2017.
- Year-over-year, Long-Term Debt Repayments sank 1816.71% in 2014 and jumped 13426.8% in 2016.
- Tracing VRTX's Long-Term Debt Repayments over 5 years: stood at -$272.9 million in 2014, then jumped by 107.21% to $19.7 million in 2015, then plunged by 78.31% to $4.3 million in 2016, then gained by 7.97% to $4.6 million in 2017, then jumped by 76.56% to $8.1 million in 2018.
- The last three Long-Term Debt Repayments figures came in at $8.1 million (Q4 2018), $5.7 million (Q3 2018), and $4.9 million (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 8.13 Mn |
| Dec 31, 2018 | 8.13 Mn |
| Sep 30, 2018 | 5.73 Mn |
| Sep 30, 2018 | 5.73 Mn |
| Jun 30, 2018 | 4.86 Mn |
| Jun 30, 2018 | 4.86 Mn |
| Mar 31, 2018 | 9.20 Mn |
| Mar 31, 2018 | 9.20 Mn |
| Dec 31, 2017 | 4.61 Mn |
| Dec 31, 2017 | 4.61 Mn |
| Sep 30, 2017 | 3.55 Mn |
| Sep 30, 2017 | 3.55 Mn |
| Jun 30, 2017 | 5.93 Mn |
| Jun 30, 2017 | 5.93 Mn |
| Mar 31, 2017 | 4.70 Mn |
| Mar 31, 2017 | 4.70 Mn |
| Dec 31, 2016 | 4.27 Mn |
| Dec 31, 2016 | 4.27 Mn |
| Sep 30, 2016 | 13.12 Mn |
| Sep 30, 2016 | 13.12 Mn |
| Jun 30, 2016 | 106,000.00 |
| Jun 30, 2016 | 106,000.00 |
| Mar 31, 2016 | 103,000.00 |
| Mar 31, 2016 | 103,000.00 |
| Dec 31, 2015 | 19.67 Mn |
| Dec 31, 2015 | 19.67 Mn |
| Sep 30, 2015 | 97,000.00 |
| Sep 30, 2015 | 97,000.00 |
| Jun 30, 2015 | 93,000.00 |
| Jun 30, 2015 | 93,000.00 |
| Mar 31, 2015 | 91,000.00 |
| Mar 31, 2015 | 91,000.00 |
| Dec 31, 2014 | -272.94 Mn |
| Dec 31, 2014 | -272.94 Mn |
| Sep 30, 2014 | 264.09 Mn |
| Sep 30, 2014 | 264.09 Mn |
| Jun 30, 2014 | 15.15 Mn |
| Jun 30, 2014 | 15.15 Mn |
| Mar 31, 2014 | 15.15 Mn |
| Mar 31, 2014 | 15.15 Mn |
| Dec 31, 2013 | 15.90 Mn |
| Dec 31, 2013 | 15.90 Mn |
| Sep 30, 2013 | -12.09 Mn |
| Sep 30, 2013 | -12.09 Mn |
| Jun 30, 2013 | 2.15 Mn |
| Jun 30, 2013 | 2.15 Mn |
| Mar 31, 2013 | 10.10 Mn |
| Mar 31, 2013 | 10.10 Mn |
| Dec 31, 2012 | -2.41 Mn |
| Dec 31, 2012 | -2.41 Mn |
| Sep 30, 2012 | 2.41 Mn |
| Sep 30, 2012 | 2.41 Mn |
| Dec 31, 2011 | 105.00 Mn |
| Dec 31, 2011 | 105.00 Mn |
| Mar 31, 2011 | 50.00 Mn |
| Mar 31, 2011 | 50.00 Mn |